Skip to main content
logo
Prescient Therapeutics Limited (ASX:PTX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0850
+0.0030 (3.66%)
Jul 31, 2026, 4:10 PM AEST

Prescient Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
89353165101157
Market Cap Growth
146.63%15.79%-53.08%-35.69%-35.43%637.70%
Enterprise Value
8027124487139
Last Close Price
0.090.040.040.080.150.24

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-5.245.245.245.245.24
PS Ratio
20.958.138.2426.8653.68132.49
PB Ratio
5.273.111.692.506.057.69
P/TBV Ratio
5.833.641.862.877.579.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
18.736.213.2818.2345.86116.91

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.02-0.02--0.01
Net Debt / Equity Ratio
-0.56-0.61-0.78-0.84-0.73-0.78
Net Debt / EBITDA Ratio
-0.921.972.942.363.76
Net Debt / FCF Ratio
1.190.961.923.542.854.02
Asset Turnover
0.240.250.150.110.100.07
Quick Ratio
12.103.757.9512.0917.3133.72
Current Ratio
12.954.088.0812.2117.6134.19
Return on Equity (ROE)
-54.33%-49.72%-37.32%-32.70%-27.52%-26.25%
Return on Assets (ROA)
-31.75%-26.95%-18.52%-20.39%-16.88%-16.05%
Return on Capital Employed (ROCE)
-51.80%-66.10%-39.80%-28.60%-31.00%-20.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-9.91%-20.66%-26.92%-10.74%-5.05%-2.64%
FCF Yield
-8.95%-20.44%-24.17%-9.49%-4.26%-2.53%
Buyback Yield / Dilution
-12.27%--10.69%-12.31%-5.88%-55.18%